Filter News
Area of Research
- (-) Neutron Science (18)
- Biology and Environment (19)
- Clean Energy (19)
- Computational Biology (1)
- Energy Frontier Research Centers (1)
- Fusion and Fission (1)
- Materials (42)
- Materials for Computing (9)
- National Security (3)
- Nuclear Science and Technology (1)
- Quantum information Science (1)
- Supercomputing (24)
News Topics
- (-) Coronavirus (8)
- (-) Nanotechnology (10)
- 3-D Printing/Advanced Manufacturing (26)
- Advanced Reactors (2)
- Artificial Intelligence (7)
- Big Data (2)
- Bioenergy (7)
- Biology (6)
- Biomedical (12)
- Biotechnology (1)
- Chemical Sciences (3)
- Clean Water (2)
- Climate Change (1)
- Composites (4)
- Computer Science (14)
- Cybersecurity (2)
- Decarbonization (2)
- Energy Storage (6)
- Environment (8)
- Fossil Energy (1)
- Frontier (1)
- Fusion (2)
- High-Performance Computing (2)
- Machine Learning (4)
- Materials (18)
- Materials Science (27)
- Mathematics (1)
- Microscopy (3)
- National Security (2)
- Neutron Science (101)
- Nuclear Energy (5)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (2)
- Space Exploration (4)
- Summit (6)
- Sustainable Energy (7)
- Transformational Challenge Reactor (1)
- Transportation (5)
Media Contacts
ORNL’s Fulvia Pilat and Karren More recently participated in the inaugural 2023 Nanotechnology Infrastructure Leaders Summit and Workshop at the White House.
The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Scientists at ORNL and the University of Tennessee, Knoxville, have found a way to simultaneously increase the strength and ductility of an alloy by introducing tiny precipitates into its matrix and tuning their size and spacing.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
Two scientists with the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Physical Society.